New tool aims to help pregnant women navigate genetic testing decisions
NCT ID NCT03420274
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a shared decision-making tool called NEST to help pregnant women understand and choose noninvasive prenatal testing (NIPT). Over 600 pregnant women participated, comparing those who used the tool with those who received usual care. The goal was to see if the tool improved informed decision-making about genetic screening.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- shared decision-making tool (NEST)
- What this could lead to
- If successful, this could improve how doctors and patients discuss prenatal genetic testing, leading to more informed choices.
- What could go wrong
- This is a behavioral study, not a treatment trial. Results may not apply to all clinics or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
691 people
The number who actually took part.
- Started
-
Feb 2018
- Finished
-
Jun 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
I. Pregnant women Inclusion criteria: 1. 18 years of age or older 2. Present for their initial prenatal visit care with one of the providers enrolled in the study 3. Able to provide consent to participate in the study 4. Available for a follow up in the 1st or 2nd trimester of pregnancy 5. Have a viable intrauterine pregnancy 6. Present for care between 7-12 weeks estimated gestation age (EGA) Since criteria 5 and 6 will not be determined until the conclusion of the first prenatal visit, women who meet criteria 1-4 will be eligible for participation. Exclusion Criteria: Women who are: 1. Less than 18 years of age 2. Not currently pregnant or an intrauterine pregnancy has not yet been established 3. Inability to provide informed consent for research participation II. Self-identified partners of pregnant women Inclusion criteria: 1. 18 years of age or older 2. The male or female partner (such as partner or mother/aunt/grandmother serving in the role of primary collaborative decision-maker in place of a partner) of a pregnant woman who has participated in the research 3. Participating in decision-making about the pregnancy 4. Ability to read and speak English 5. Ability to provide informed consent for research participation Exclusion criteria: 1. Younger than 18 years of age 2. Not currently involved in the pregnancy or decision-making about prenatal care 3. Inability to speak or read English 4. Inability to provide informed consent for research participation III. Prenatal healthcare providers Inclusion criteria: 1. Board certified or board-eligible CNM, OB/GYNs or MFMs 2. Deliver outpatient prenatal care at one of the regional practices of the Cleveland Clinic 3. Able to read and speak English 4. Able to provide consent for research participation Exclusion criteria: 1. OB/GYNs who do not currently provide prenatal care 2. Medical students, residents, and fellows 3. Hospitalists who do not provide outpatient obstetric care
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Genetic disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood draw map a Baby's genetic risks?
- A gene variant found mostly on one island could reshape breast cancer screening
- Can diet and exercise in pregnancy shape a Child's health for years?
- Gut microbes in pregnancy and infancy: a window into lifelong health?
- Hidden gut inflammation may drive familial mediterranean fever
- Could more doula visits ease postpartum depression?